A detailed history of Ballew Advisors, Inc transactions in Haleon PLC stock. As of the latest transaction made, Ballew Advisors, Inc holds 12,859 shares of HLN stock, worth $125,246. This represents 0.09% of its overall portfolio holdings.

Number of Shares
12,859
Previous 12,856 0.02%
Holding current value
$125,246
Previous $106,000 28.3%
% of portfolio
0.09%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$8.32 - $10.7 $24 - $32
3 Added 0.02%
12,859 $136,000
Q2 2024

Jul 17, 2024

BUY
$8.01 - $8.64 $2,074 - $2,237
259 Added 2.06%
12,856 $106,000
Q4 2023

Jan 18, 2024

BUY
$7.78 - $8.62 $23 - $25
3 Added 0.02%
12,597 $103,000
Q1 2023

Jul 06, 2023

BUY
$7.57 - $8.37 $30 - $33
4 Added 0.03%
12,594 $102,000
Q3 2022

Oct 11, 2022

BUY
$5.63 - $7.5 $70,881 - $94,425
12,590 New
12,590 $75,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Ballew Advisors, Inc Portfolio

Follow Ballew Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballew Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ballew Advisors, Inc with notifications on news.